Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study.
Saved in:
| Title: | Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study. |
|---|---|
| Authors: | Glorieux FH; Departments of Surgery, Pediatrics and Human Genetics, Shriners Hospitals for Children, McGill University, Montreal, Quebec H4A 0A9, Canada., Langdahl B; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Middle Jutland 8200, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Middle Jutland 8200, Denmark., Chapurlat R; Inserm UMR 1033, Edouard Herriot Hospital, 69372 Lyon cedex 08, France., De Beur SJ; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States., Sutton VR; Department of Molecular & Human Genetics, Baylor College of Medicine & Texas Children's Hospital, Houston, TX 77030, United States., Poole KES; Department of Medicine & Cambridge NIHR Biomedical Research Centre, University of Cambridge, Cambridge CB3 0FA, United Kingdom., Dahir KM; Division of Endocrinology, Vanderbilt University Medical Center, Nashville, TN 37232, United States., Orwoll ES; Division of Endocrinology, Diabetes and Clinical Nutrition, School of Medicine, Oregon Health & Sciences University, Portland, OR 97239, United States., Willie BM; Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal H3A 2T5, Canada.; Shriners Hospitals for Children, Montreal, Quebec H4A 0A9, Canada., Mikolajewicz N; Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal H3A 2T5, Canada.; Shriners Hospitals for Children, Montreal, Quebec H4A 0A9, Canada., Zimmermann E; Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal H3A 2T5, Canada.; Shriners Hospitals for Children, Montreal, Quebec H4A 0A9, Canada., Hosseinitabatabaei S; Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal H3A 2T5, Canada.; Shriners Hospitals for Children, Montreal, Quebec H4A 0A9, Canada., Ominsky MS; Ultragenyx Pharmaceutical Inc., Novato, CA 94949, United States., Saville C; ICON Plc, Leopardstown, Dublin D 18, Ireland., Clancy J; Mereo BioPharma, London W16 0QF, United Kingdom., MacKinnon A; Mereo BioPharma, London W16 0QF, United Kingdom., Mistry A; Mereo BioPharma, London W16 0QF, United Kingdom., Javaid MK; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Wellington Square, Oxford OX1 2JD, United Kingdom. |
| Source: | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2024 Sep 02; Vol. 39 (9), pp. 1215-1228. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8610640 Publication Model: Print Cited Medium: Internet ISSN: 1523-4681 (Electronic) Linking ISSN: 08840431 NLM ISO Abbreviation: J Bone Miner Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39012717 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Glorieux+FH%22">Glorieux FH</searchLink>; Departments of Surgery, Pediatrics and Human Genetics, Shriners Hospitals for Children, McGill University, Montreal, Quebec H4A 0A9, Canada.<br /><searchLink fieldCode="AU" term="%22Langdahl+B%22">Langdahl B</searchLink>; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Middle Jutland 8200, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Middle Jutland 8200, Denmark.<br /><searchLink fieldCode="AU" term="%22Chapurlat+R%22">Chapurlat R</searchLink>; Inserm UMR 1033, Edouard Herriot Hospital, 69372 Lyon cedex 08, France.<br /><searchLink fieldCode="AU" term="%22De+Beur+SJ%22">De Beur SJ</searchLink>; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.<br /><searchLink fieldCode="AU" term="%22Sutton+VR%22">Sutton VR</searchLink>; Department of Molecular & Human Genetics, Baylor College of Medicine & Texas Children's Hospital, Houston, TX 77030, United States.<br /><searchLink fieldCode="AU" term="%22Poole+KES%22">Poole KES</searchLink>; Department of Medicine & Cambridge NIHR Biomedical Research Centre, University of Cambridge, Cambridge CB3 0FA, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dahir+KM%22">Dahir KM</searchLink>; Division of Endocrinology, Vanderbilt University Medical Center, Nashville, TN 37232, United States.<br /><searchLink fieldCode="AU" term="%22Orwoll+ES%22">Orwoll ES</searchLink>; Division of Endocrinology, Diabetes and Clinical Nutrition, School of Medicine, Oregon Health & Sciences University, Portland, OR 97239, United States.<br /><searchLink fieldCode="AU" term="%22Willie+BM%22">Willie BM</searchLink>; Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal H3A 2T5, Canada.; Shriners Hospitals for Children, Montreal, Quebec H4A 0A9, Canada.<br /><searchLink fieldCode="AU" term="%22Mikolajewicz+N%22">Mikolajewicz N</searchLink>; Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal H3A 2T5, Canada.; Shriners Hospitals for Children, Montreal, Quebec H4A 0A9, Canada.<br /><searchLink fieldCode="AU" term="%22Zimmermann+E%22">Zimmermann E</searchLink>; Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal H3A 2T5, Canada.; Shriners Hospitals for Children, Montreal, Quebec H4A 0A9, Canada.<br /><searchLink fieldCode="AU" term="%22Hosseinitabatabaei+S%22">Hosseinitabatabaei S</searchLink>; Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal H3A 2T5, Canada.; Shriners Hospitals for Children, Montreal, Quebec H4A 0A9, Canada.<br /><searchLink fieldCode="AU" term="%22Ominsky+MS%22">Ominsky MS</searchLink>; Ultragenyx Pharmaceutical Inc., Novato, CA 94949, United States.<br /><searchLink fieldCode="AU" term="%22Saville+C%22">Saville C</searchLink>; ICON Plc, Leopardstown, Dublin D 18, Ireland.<br /><searchLink fieldCode="AU" term="%22Clancy+J%22">Clancy J</searchLink>; Mereo BioPharma, London W16 0QF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22MacKinnon+A%22">MacKinnon A</searchLink>; Mereo BioPharma, London W16 0QF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mistry+A%22">Mistry A</searchLink>; Mereo BioPharma, London W16 0QF, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Javaid+MK%22">Javaid MK</searchLink>; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Wellington Square, Oxford OX1 2JD, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228610640%22">Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</searchLink> [J Bone Miner Res] 2024 Sep 02; Vol. 39 (9), pp. 1215-1228. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8610640 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-4681 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208840431%22">08840431 </searchLink><i>NLM ISO Abbreviation: </i>J Bone Miner Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39012717 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jbmr/zjae112 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1215 Titles: – TitleFull: Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Glorieux FH – PersonEntity: Name: NameFull: Langdahl B – PersonEntity: Name: NameFull: Chapurlat R – PersonEntity: Name: NameFull: De Beur SJ – PersonEntity: Name: NameFull: Sutton VR – PersonEntity: Name: NameFull: Poole KES – PersonEntity: Name: NameFull: Dahir KM – PersonEntity: Name: NameFull: Orwoll ES – PersonEntity: Name: NameFull: Willie BM – PersonEntity: Name: NameFull: Mikolajewicz N – PersonEntity: Name: NameFull: Zimmermann E – PersonEntity: Name: NameFull: Hosseinitabatabaei S – PersonEntity: Name: NameFull: Ominsky MS – PersonEntity: Name: NameFull: Saville C – PersonEntity: Name: NameFull: Clancy J – PersonEntity: Name: NameFull: MacKinnon A – PersonEntity: Name: NameFull: Mistry A – PersonEntity: Name: NameFull: Javaid MK IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Sep 02 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1523-4681 Numbering: – Type: volume Value: 39 – Type: issue Value: 9 Titles: – TitleFull: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research Type: main |
| ResultId | 1 |